Pharmacy DX Solution 'enpas' Surpasses 10 Million Patients Receiving Health Support Information, Enhancing Support for Additional Fees and Operational Efficiency in Preparation for the 2026 Dispensing Fee Revision
NQ Score
50/100
AI Summary (NQ-processed)
Pharmacy DX 'enpas' exceeds 10 million patients receiving health support information, strengthening its response to dispensing fee revisions.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What is the cumulative number of patients who have received health support information through 'enpas'?
- A: As of March 2026, we have surpassed a cumulative total of 10 million patients.
- Q: What specific tasks does 'enpas' streamline?
- A: 'enpas' automates and visualizes the preparation of guidance sheets and checklists according to prescriptions, information provision to hospitals, and the process for claiming specific drug management and guidance fees, thereby reducing the administrative workload for pharmacists.
- Q: How does 'enpas' help with the 2026 dispensing fee revision?
- A: As the evaluation of interpersonal services becomes stricter, 'enpas' contributes to the stabilization of pharmacy management by systematizing high-quality interventions and supporting the acquisition of additional fees.
- Q: Are there specific effects from introducing 'enpas'?
- A: There are cases where information provided to medical institutions has increased approximately fivefold, and material preparation time has been reduced by about 10 minutes per prescription. Furthermore, improvements in medication adherence and increased repeat visits due to becoming a community pharmacy are also expected.